Holen Sie sich die Stockscreener-App
240.47
2.75%
6.4348
Schlusskurs vom Vortag:
$234.03
Offen:
$234.08
24-Stunden-Volumen:
10,884
Relative Volume:
0.94
Marktkapitalisierung:
$480.09M
Einnahmen:
Nettoeinkommen (Verlust:
KGV:
-
EPS:
-
Netto-Cashflow:
1W Leistung:
+1.27%
1M Leistung:
+4.00%
6M Leistung:
+26.85%
1J Leistung:
+37.65%
1-Tages-Spanne:
$234.08
$240.47
1-Wochen-Bereich:
$230.25
$243.69
52-Wochen-Spanne:
$171.63
$246.55
Vaneck Biotech Etf Stock (BBH) Company Profile
Firmenname
Vaneck Biotech Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare BBH vs VOO, IVV, SPY, VTI, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBH
Vaneck Biotech Etf
|
240.47 | 480.09M | 0 | 0 | 0 | 0.00 |
VOO
Vanguard S P 500 Etf
|
715.59 | 1.06T | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
781.97 | 898.64B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
778.57 | 833.41B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
381.94 | 697.19B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
751.27 | 506.81B | 0 | 0 | 0 | 0.00 |
Vaneck Biotech Etf Aktie (BBH) Neueste Nachrichten
VEFU ETF Holdings List — HAN:VEFU - tradingview.com
VEFU ETF Profile: Dividends, Returns (HAN:VEFU) - tradingview.com
VEFU ETF Price and Chart — HAN:VEFU - tradingview.com
Fidelity Healthcare ETF (FHLC) vs. VanEck Biotech ETF (BBH): Which Fund Is the Better Buy? - The Motley Fool
Fidelity Healthcare ETF (FHLC) vs. VanEck Biotech ETF (BBH): Which Fund Is the Better Buy? - The Globe and Mail
Fidelity Healthcare ETF (FHLC) vs. VanEck Biotech ETF (BBH): Which Fund Is the Better Buy? - The Globe and Mail
Fidelity Healthcare ETF (FHLC) vs. VanEck Biotech ETF (BBH): Which Fund Is the Better Buy? - The Globe and Mail
Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate - Zacks Investment Research
Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate - TradingView
Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate - TradingView
Should You Invest in the VanEck Biotech ETF (BBH)? - Yahoo Finance
VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits? - The Motley Fool
VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits? - aol.com
VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits? - The Globe and Mail
Steak 'n Shake Bitcoin Bonus Offers Hourly Workers $438 Annually With Two-Year Wait - Yellow.com
Steak 'n Shake Bitcoin Bonus Offers Hourly Workers $438 Annually With Two-Year Wait - yellow.com
7 Best Biotech ETFs to Buy Now | Investing - US News Money
Steak 'n Shake Reports 19% Same-Store Sales Growth After Adopting Bitcoin Payments - finance.biggo.com
(BH) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Trading Systems Reacting to (BH.A) Volatility - Stock Traders Daily
Should You Invest in the VanEck Biotech ETF (BBH)? - Eastern Progress
Biglari Holdings Inc (BH) Shares Surge 3.0% -- What GF Score of 54 Tells Investors - GuruFocus
Steak ‘n Shake’s MAGA Makeover Is Winning Fans but Its Stock Is Complicated - Barron's
Steak 'n Shake Declares Itself a Bitcoin Company After 13.8% Same-Store Sales Surge - finance.biggo.com
Why a Famous Burger Chain Now Calls Itself a ‘Bitcoin Company’ - Cryptonews.net
Behavioral Patterns of BH and Institutional Flows - Stock Traders Daily
How to Choose Between Two Major Pharmaceutical Themed ETFs? - nai500.com
Which Healthcare ETF Offers the Better Growth Outlook: VanEck Biotech or Invesco Pharmaceuticals? - The Motley Fool
Biglari Sardar Makes New $8.30 Million Investment in El Pollo Loco Holdings, Inc. $LOCO - MarketBeat
Which Healthcare ETF Offers the Better Growth Outlook: VanEck Biotech or Invesco Pharmaceuticals? - Yahoo Finance
Biglari Sardar Buys New Position in Coca-Cola Consolidated, Inc. $COKE - MarketBeat
VanEck Biotech ETF (BBH) is a Buy with strong g... - Pluang
BBH: Biotech’s Next Growth Cycle Is Just Getting Started (NASDAQ:BBH) - Seeking Alpha
Biglari (BH) Results at a Glance: The Report Provides a New Financial Snapshot at the Close; Trading Move: Shares Finish 0.52% Down in the Latest SessionProfit Recovery Report - vinanet.vn
Which Biotech ETF Is a Better Buy: Concentrated Bet or Broad Basket? - The Motley Fool
The Zacks Analyst Blog Highlights Amgen, Crinetics, FBT, BBH and BBP - Eastern Progress
In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech? - The Motley Fool
Bet on These Biotech ETFs as Innovation Drives Market-Beating Growth - TradingView
In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech? - Yahoo Finance
Bet on These Biotech ETFs as Innovation Drives Market-Beating Growth - Eastern Progress
Healthcare ETFs Are Looking Up: Here's Why - TradingView
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI? - sharewise.com
These 2 Stocks Are Setting Off Technical Alarm Bells with $1,000+ Price Tags. Here’s the Company I’d Bet on for the Long Term. - Barchart.com
Biglari (NYSE:BH) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI? - The Globe and Mail
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI? - The Motley Fool
These 2 Stocks Are Setting Off Technical Alarm Bells with $1,000+ Price Tags. Here’s the Company I’d Bet on for the Long Term. - Yahoo Finance
Discipline and Rules-Based Execution in BH.A Response - Stock Traders Daily
Biglari Holdings (BH) Slips 0.81% as Shares Test Key Support ZoneTWAP Entry - dars.gov.et
Biglari Holdings (BH) Slips 0.81% as Shares Test Key Support ZoneVolume Nodes - vinanet.vn
Finanzdaten der Vaneck Biotech Etf-Aktie (BBH)
Es liegen keine Finanzdaten für Vaneck Biotech Etf (BBH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
0.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):